Medicenna Therapeutics Corp. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-11-10: Form 6-K; Period of report 2022-11-10; Description FORM 6-K; Document f6k_111022.htm.
- 2022-11-04: Form 6-K; Period of report 2022-09-30; Description FORM 6-K; Document f6k_110322.htm.
- 2022-10-28: Form 6-K; Period of report 2022-10-28; Description FORM 6-K; Document f6k_102722.htm.
- 2022-10-25: Form 6-K; Period of report 2022-10-25; Description FORM 6-K; Document f6k_102522.htm.